Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Investment Fraud Lawyers Cite “Serious Flaws” in FINRA Arbitration Panels October 10, 2014 Irvin Jackson Add Your Comments A group of attorneys who represent investors in claims against stock brokers and the financial industry is criticizing the independent regulatory organization through which all cases must be pursued, saying that arbitrators used lack diversity and transparency, and that investors should be able to take their grievances to court instead of being forced into binding arbitration. The Public Investors Arbitration Bar Association (PIABA) released a report this week titled “The Importance of Arbitrator Disclosure” (PDF), which criticizes the hiring and vetting process used by Financial Industry Regulatory Authority (FINRA) for arbitration panels used to decide investment fraud lawsuits. FINRA is a non-governmental agency that acts as a self-regulator for investment firms. It was created in July 2007, as a successor to the National Association of Securities Dealers, contractually handling all disputes between investors and stockbrokers or other financial firms. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Investors are required to pursue any stock brocker fraud or misconduct claims through FINRA arbitration, including cases for breach of contract, breach of fiduciary duty, negligence, misrepresentation, unauthorized trading and other claims that investments were improperly handled. According to the PIABA report, 80% of FINRA arbitrators used to resolve conflicts between investors and stock brockerage firms are male, with an average age of 69. The report also finds that FINRA has done little to expose or investigate potential conflicts of interest among the arbitrators. The report calls FINRA’s arbitrator disclosure process “illusory” and determined that it fails to provide meaningful and reliable information about arbitrators’ bias and possible conflicts of interest. FINRA has failed to disclose to either the public or those involved in arbitration how and why arbitrators are recruited, which PIABA says is important in rooting out potential conflicts of interest. PIABA maintains that FINRA collects and has that information, but it just refuses to share it. The diversity issue is another major concern, PIABA notes. Female investors are underrepresented among the arbitrators, the group found, and there are serious concerns about the ability of arbitrators to effectively participate in deciding cases when about 40% are 70 or older and 17% are 80 or older. The average age is 69. PIABA notes that in 1992, about 60% of investors who brought arbitration claims received an award. Those awards were about 60% of the amount claimed. In 2013, under FINRA, only 47% of investors were granted an award for their grievances, and the amounts awarded have dropped. “FINRA states that the cornerstone of the integrity of its entire arbitration forum depends on FINRA having an effective and reliable process to detect and disclose arbitrators’ biases and conflicts of interest to the parties. PIABA has showed that FINRA’s arbitrator disclosure process fails at every step,” PIABA President Jason R. Doss said in a press release. “Therefore, investors have no other choice but to conclude that arbitration is unfair. The sad state of FINRA arbitration today is the most powerful argument that can be made for Congress to give investors the option to go to court.” SEC Involvement, Court Options Recommended The report makes a number of suggestions to rectify the situation, including a viable alternative to FINRA for investors with grievances. “If investors had a choice to seek justice in a forum other than FINRA, then many of the problems in this report would be alleviated,” the report notes. “Right now, investors are forced into FINRA’s flawed system to seek justice. PIABA believes that a viable alternative would do much to clean up FINRA’s arbitration system and, thus, urges congress to pass the Investor Choice Act of 2013 making securities arbitration optional for investors.” PIABA also calls for the U.S. Securities and Exchange Commission (SEC) to place an independent board in an oversight position to ensure transparency of FINRA’s arbitration process. It also recommends that the SEC make some FINRA documents subject to the Freedom of Information Act and to perform an independent study on how FIRA’s arbitrator recruiting practices affect the demographics of its arbitrator roster and the outcomes of arbitration cases. Tags: FINRA, FINRA Arbitration, Investment Arbitration, Investor Lawsuit More Lawsuit Stories Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge March 24, 2025 Roundup Lawsuit Verdicts Continue To Pile Up, With $2.1B Award by Georgia Jury March 24, 2025 Segway Electric Scooter Recall Issued Amid Reports of Handlebars Collapsing March 24, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: today) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025) Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 3 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025) McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (Posted: 3 days ago) An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITSteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)
Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: today) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 3 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)
McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (Posted: 3 days ago) An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITSteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)